A detailed history of Wealth Collab, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Wealth Collab, LLC holds 200 shares of MRNA stock, worth $23,750. This represents 0.02% of its overall portfolio holdings.

Number of Shares
200
Previous 229 12.66%
Holding current value
$23,750
Previous $22.8 Million 6.42%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$85.37 - $115.44 $2,475 - $3,347
-29 Reduced 12.66%
200 $21.3 Million
Q4 2023

Apr 03, 2024

BUY
$69.51 - $104.43 $15,917 - $23,914
229 New
229 $22.8 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Wealth Collab, LLC Portfolio

Follow Wealth Collab, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Collab, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Collab, LLC with notifications on news.